NF2 and neoplasm: The high abundance of tumour-associated macrophages and presence of T-cells noted in this study promote these immune cells as potential immunotherapeutic avenues to modify the tumour immune microenvironment in order to reduce tumour growth and SNHL in patients with either NF2-SWN or sporadic VS.